Online citations, reference lists, and bibliographies.

2018 Chinese Guidelines For Prevention And Treatment Of Hypertension—A Report Of The Revision Committee Of Chinese Guidelines For Prevention And Treatment Of Hypertension

L. Liu
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Revision Committee Members Chair: Li–Sheng LIU* Deputy Chairs: Zhao–Su WU, Ji–Guang WANG, Wen WANG Members (Listed in alphabetic order by last name in Chinese Pinyin) Yu–Jing BAO, Jun CAI, Lu–Yuan CHEN, Wei–Wei CHEN, Shao–Li CHU, Ying–Qing FENG, Ping–Jin GAO, Ting–Rui GUAN, Zi–Hong GUO, Qi HUA, Jun HUANG, Yong HUO, Wei–Ping JIA, Xiong–Jing JIANG, Yi–Nong JIANG, Li LI, Li–Huan LI, Nan–Fang LI, Wei LI, Xiao–Ying LI, Xue–Wang LI, Yan LI, Yong LI, Jin–Xiu LIN, Li–Sheng LIU, Xin–Zheng LU, Ji–Xiang MA, Jie MI, Jian-Jun MU, Chang–Yu PAN, Gang SUN, Ning–Ling SUN, Ying–Xian SUN, Jun TAO, Hao WANG, Ji–Guang WANG, Wen WANG, Wen–Zhi WANG, Yong–Jun WANG, Yu WANG, Zeng–Wu WANG, Hai–Ying WU, Zhao–Su WU, Liang–Di XIE, Zhang–Rong XU, Xiao–Wei YAN, Yan–Min YANG, Chong–Hua YAO, Zheng–Pei ZENG, Jian ZHANG, Wei–Zhong ZHANG, Xin–Hua ZHANG, Xin–Jun ZHANG, Yu–Qing ZHANG, Ding–Liang ZHU, Jun ZHU, Zhi–Ming ZHU
This paper references
Predictive value of Chinese adult body mass index and waist circumference for risk factors of related diseases: a study of appropriate body mass index and waist cut point
Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey
Y Wu (2002)
Primary care-based
HHX Wang (2015)
10.1016/S0140-6736(01)06411-X
Cardiovascular protection and blood pressure reduction: a meta-analysis
J. Staessen (2001)
10.7326/0003-4819-130-6-199903160-00002
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
A. Levey (1999)
10.1016/j.jclinane.2008.09.003
Perioperative hypertension: a review of current and emerging therapeutic agents.
P. Marik (2009)
10.1097/HJH.0b013e328342ef04
Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT study
G. Mancia (2011)
10.1080/00325481.2018.1423852
Canagliflozin and cardiovascular and renal events in type 2 diabetes
R. Guthrie (2018)
Zhu DL on behalf of the "China High Blood Pressure Education Guide" Compilation Committee
Z S Wu
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for Journal of Geriatric Cardiology | jgc@jgc301
P M Okin (2009)
10.1161/01.STR.0000221716.55088.d4
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
M. Bos (2006)
10.1056/NEJMoa0801317
Telmisartan, ramipril, or both in patients at high risk for vascular events.
S. Yusuf (2008)
10.1016/j.envint.2013.01.010
Systematic review of Chinese studies of short-term exposure to air pollution and daily mortality.
Y. Shang (2013)
10.1681/ASN.2006040368
Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.
Ying-chun Ma (2006)
10.1056/NEJMc1600827
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
M. Fischereder (2016)
10.1136/jnnp-2014-307856
Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial
H. Arima (2014)
Dublin outcome study
JK Johansson (2005)
A cross-sectional survey of hypertension in patients with chronic kidney disease
J Lin
Aliskiren for geritric lowering of systolic hypertension: a randomized controlled trial
DA Duprez (2010)
10.1097/00004872-200404000-00001
Genetics of primary aldosteronism
P. Mulatero (2004)
10.1056/NEJM199704173361601
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group.
L. Appel (1997)
10.1038/hr.2009.139
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
L. Liu (2009)
10.1016/j.jacc.2011.07.045
Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study).
L. Gray (2011)
10.1002/14651858.cd003075.pub2
Treatment of hypertension in peripheral arterial disease.
D. Lane (2009)
Multiple risk factor clustering
CQ Ying (2016)
10.1038/ki.2012.136
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
B. Robinson (2012)
10.1161/CIRCULATIONAHA.106.675355
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study
C. Fox (2007)
10.1161/CIR.0b013e318235eb4d
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
S. Smith (2011)
10.1056/NEJM199610033351401
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
F. Sacks (1996)
10.1007/s00246-007-9153-4
Relation of Left Ventricular Hypertrophy to Microalbuminuria and C-Reactive Protein in Children and Adolescents with Essential Hypertension
F. Assadi (2007)
10.1056/NEJMc1611289
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
L. Correia (2016)
10.1097/HJH.0000000000000602
Association of visceral and total body fat with hypertension and prehypertension in a middle-aged Chinese population
Z. Wang (2015)
10.1161/HYPERTENSIONAHA.109.146035
Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study
T. Ogihara (2010)
10.1001/ARCHINTE.160.2.211
Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group.
J. Wang (2000)
Metabolic Syndrome---Etiology Exploration and Clinical Practice. Prevention and Treatment of Metabolic Syndrome
Z M Zhu (2005)
Target blood pressure
Trialists’ Collaboration (2000)
The position and recommendations of the Chinese Hypertension League on percutaneous transluminal radiofrequency ablation of renal sympathetic nerve for the treatment of refractory hypertension
ZS Wu (2013)
Beijing: People's Medical Publishing House
Y M Hu (2002)
10.1016/S0140-6736(14)61774-8
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
R. Schnabel (2015)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.
F. Sacks (2001)
10.1542/peds.2012-1292
Prehypertension and Hypertension in Community-Based Pediatric Practice
J. Lo (2013)
10.1007/s00467-006-0068-8
Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension
M. Litwin (2006)
10.7326/0003-4819-131-5-199909070-00006
Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study
A. Bostom (1999)
10.1093/eurheartj/ehr039
Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.
Y. Zhang (2011)
Prevalence and trends of isolated systolic
NR Kim (2001)
To formulate strategies and programs for prevention and treatment of hypertension in China according to the characteristics of hypertension in China
W Wang (2010)
Effects of ACE
B Neal (2001)
Chinese trial on isolated
JG Wang (2015)
Diabetes Branch of Chinese Medical Association. Guidelines for the prevention and treatment of type 2 Diabetes in China
(2017)
Study of left ventricular structural damage in patients with primary aldosteronism
NF Li (2012)
Survey of prevalence, awareness, treatment rate and control rate of hypertension in rural areas in four northern districts in
G H Fan (2013)
Pregnancy outcomes in women with chronic hypertension: a populationbased study
W M Gilbert (2007)
Department of Hypertension, Chinese Medical Association Cardiovascular Disease Branch
10.1097/MNH.0b013e3282f0d107
Evaluation of blood pressure in children
M. Sinha (2007)
10.1161/HYPERTENSIONAHA.108.189141
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
D. Calhoun (2008)
10.1016/J.JACC.2004.06.080
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
K. Wachtell (2005)
10.1016/J.CLINTHERA.2007.07.029
Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective.
D. Coyle (2007)
A multicenter randomized, double-blind, controlled clinical trial of antihypertensive therapy for stroke recurrence
L S Liu
A multicenter randomized
LS (2014)
10.1016/b978-0-444-64189-2.00024-x
Drug treatment.
Susan L. Perlman (2018)
Journal of Geriatric Cardiology and hypertension: a systematic review and meta-analysis of epidemiological studies
(2015)
10.1016/j.amjcard.2010.12.016
Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension.
Firas J Al Badarin (2011)
10.1097/AOG.0b013e3181e9322a
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis
E. Bujold (2010)
10.1016/s1701-2163(15)30588-0
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.
L. Magee (2014)
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Sc Prospective (2002)
10.1001/jama.1966.03100050043015
Prognostic importance of ophthalmoscopic findings in essential hypertension.
Donald J. Breslin (1966)
10.1136/bmj.312.7041.1249
Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations
P. Elliott (1996)
10.1159/000095736
Antiproteinuric Effect of Losartan in Non-Diabetic Renal Disease Is Not Dependent on ACE Insertion/Deletion Polymorphism
H. Park (2006)
10.1038/hr.2014.20
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
K. Shimamoto (2014)
DL on behalf of the "China High Blood Pressure Education Guide" Compilation Committee. [Chinese Hypertension Patients Education Guide
ZS Wu (2013)
Blood pressure lowering
CA Emdin (2017)
10.3760/CMAJ.ISSN.0366-6999.20130835
Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients.
Y. Zheng (2013)
[Hypertension and anesthesia].
H. Heitmann (1967)
10.1136/bmj.297.6644.319
Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group.
G. Scally (1988)
10.1097/HJH.0000000000000221
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.
G. Parati (2014)
10.1016/S0140-6736(15)01225-8
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad (2016)
10.1161/HYPERTENSIONAHA.114.04262
Home Blood Pressure and Cardiovascular Outcomes in Patients During Antihypertensive Therapy: Primary Results of HONEST, a Large-Scale Prospective, Real-World Observational Study
K. Kario (2014)
10.1016/S0140-6736(04)16456-8
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
M. Weber (2004)
10.2337/dc10-2415
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
R. Wing (2011)
10.1016/j.amepre.2015.04.014
Secondhand Smoke Exposure and Stroke: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
A. Malek (2015)
10.1007/s12170-009-0036-5
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
D. Lloyd-Jones (2009)
10.1038/srep38768
A nationwide cross-sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease
W. Zhang (2016)
Development of a simplified blood pressure standard for children aged 3 to 17 years in China
H Fan (2017)
Prevalence of and risk factors
E Selvin (2016)
Prevalence, awareness, teatment, control and risk factors associated with hypertension among adults in Southern China
L Yang (2013)
Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease
M Zhou (2013)
10.1097/00004872-200105000-00008
Diagnosis of Liddle syndrome by genetic analysis of beta and gamma subunits of epithelial sodium channel--a report of five affected family members.
P. Gao (2001)
10.1161/CIRCULATIONAHA.104.515072
Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China: Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia)
Dongfeng Gu (2005)
10.1001/jamainternmed.2016.4687
Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
X. Xu (2016)
10.1161/CIRCULATIONAHA.108.830042
Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women
D. Conen (2009)
10.1212/WNL.0000000000003909
Meta-analysis of folic acid efficacy trials in stroke prevention
Min Zhao (2017)
10.1093/ajh/hpt186
Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns.
Z. Wang (2014)
10.1038/jhh.2014.123
Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China
H. Gu (2015)
10.1016/j.jash.2015.02.012
Renal denervation therapy for hypertension: pathways for moving development forward.
W. White (2015)
652–625. [In Chinese
J Chin (2008)
Predictive value of adult body mass index and waist circumference for risk factors associated with disease: a study of appropriate body mass index and waist circumference
Catheterbased renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
RR Townsend (2017)
10.1001/ARCHINTE.158.11.1197
Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure.
W. Cushman (1998)
10.1016/j.rec.2016.11.033
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.
P. Kirchhof (2017)
10.1097/01.hjh.0000199800.72563.26
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials
H. Dickinson (2006)
10.1056/NEJMOA011489
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.
H. Parving (2001)
10.1007/S11906-003-0018-9
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.
N. Hollenberg (2003)
10.1001/ARCHINTE.163.16.1939
The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study.
J. Murabito (2003)
10.1001/JAMA.291.11.1342
Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.
G. Bobrie (2004)
10.1161/HYPERTENSIONAHA.110.150771
Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously.
G. Stergiou (2010)
10.1001/jama.2010.884
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
R. Cooper-DeHoff (2010)
Age-specific rele
S Lewington (2013)
Practical Pediatrics]. Beijing: People's Medical Publishing House; 2002. [In Chinese
FT HuYM.Zhu (2002)
Degree of blood
H Arima (2010)
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure in East Asians
N Kato (2011)
Aggregation analysis of overweight/obesity and cardiovascular risk factors in middleaged population in China
Z W Wang
10.1161/HYPERTENSIONAHA.111.00003
Association Between Long-Term Air Pollution and Increased Blood Pressure and Hypertension in China
G. Dong (2013)
10.1038/hr.2010.259
Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association
J. Wang (2011)
10.1161/CIR.0b013e31828b82aa
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J. Anderson (2013)
10.1056/NEJM199601043340103
Blood pressure and end-stage renal disease in men.
M. Klag (1996)
10.3945/ajcn.116.143131
Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT).
Xianhui Qin (2017)
10.1093/EURHEARTJ/EHL254
Expert consensus document on arterial stiffness: methodological issues and clinical applications.
S. Laurent (2006)
10.1097/01.HJH.0000052492.18130.07
Blood pressure and cardiovascular disease in the Asia Pacific region
C. Lawes (2003)
10.1016/j.cjca.2016.02.066
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Alexander A. Leung (2016)
10.1097/00008483-199205000-00014
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
(1991)
10.1093/ajh/hpt163
Blood pressure responses to dietary sodium and potassium interventions and the cold pressor test: the GenSalt replication study in rural North China.
Q. Zhao (2014)
10.1016/j.jacc.2014.03.049
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.
S. Halvorsen (2014)
10.1016/S0140-6736(99)07330-4
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
J. Staessen (2000)
Prevention of pree
E Bujold (2015)
Revision Committee of the Guidelines for the Prevention and Treatment of Hypertension in China. [Guidelines for the Prevention and Treatment of Hypertension in China
(2005)
The Felodipine Event Reduction
L Liu (2000)
10.1161/HYPERTENSIONAHA.106.085910
Blood Pressure and Retinal Arteriolar Narrowing in Children
P. Mitchell (2007)
10.5860/choice.26-6129
Blood Pressure
J. Murray (1911)
10.1016/S0140-6736(14)62053-5
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial
M. Lobo (2015)
10.2337/dc14-S014
Standards of Medical Care in Diabetes—2014
F. Wolf (2013)
Anxiety in depression.
J. J. Schwab (1984)
10.1093/eurjhf/hfq038
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trial
D. Castagno (2010)
10.1111/jch.13201
Performance of 4 definitions of childhood elevated blood pressure in predicting subclinical cardiovascular outcomes in adulthood
H. Fan (2018)
10.1038/sj.ijo.0802982
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice
J. Douketis (2005)
Analysis of proteinuria in patients with primary aldosteronism
N Li (2013)
Shanghai trial of nifedipine
W Zhang (1998)
Association between anxiety
W Cai (2012)
10.7326/0003-4819-150-9-200905050-00006
A new equation to estimate glomerular filtration rate.
A. Levey (2009)
10.1542/peds.2017-1904
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
J. Flynn (2017)
10.1038/srep27627
Clustering of cardiovascular behavioral risk factors and blood pressure among people diagnosed with hypertension: a nationally representative survey in China
Y. Li (2016)
The Global Burden of Disease Study
C. Murray (2003)
10.1136/bmj.39147.604896.55
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)
N. Cook (2007)
10.15288/JSAD.2017.78.375
Alcohol Consumption and Mortality From Coronary Heart Disease: An Updated Meta-Analysis of Cohort Studies.
J. Zhao (2017)
10.7326/M16-0577
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.
K. Bibbins-Domingo (2016)
10.1097/HJH.0b013e328333b009
Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
H. Arima (2010)
10.2105/AJPH.2012.301153
Job strain and ambulatory blood pressure: a meta-analysis and systematic review.
P. Landsbergis (2013)
10.1056/NEJMoa1310907
Edoxaban versus warfarin in patients with atrial fibrillation.
R. Giugliano (2013)
10.1097/HJH.0000000000001025
Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study – a randomized controlled trial
A. Oliveras (2016)
Study on the detection rate of sleep apnea hypopnea syndrome in hypertensive patients with different body mass index
NF Li (2012)
Hypertensive intervention trial
TJ Zhang (1996)
Multi-center, prospective Chinese heart failure registration study -preliminary analysis of etiology, clinical features and treatment
J Zhang
Prognostic value
PM Okin (2016)
A longitudinal control survey of blood pressure in 412 children in Beijing after 18 years
MM Zhang (2006)
Comparative study on the effects of hypertension management in rural communities
ZW Wang (2015)
Lifetime risk
DM Lloyd-Jones (2003)
A follow-up study on the relationship between overweight and obesity and hypertension in Chinese adults
B Y Feng
Title Evaluation of the quality of care of a multi-disciplinary Risk Factor Assessment and Management Programme for Hypertension
Esther Yee Tak Yu (2015)
10.1097/01.hjh.0000160223.94220.29
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial
J. Lubsen (2005)
10.1161/CIRCULATIONAHA.107.732131
Trends and Cardiovascular Mortality Effects of State-Level Blood Pressure and Uncontrolled Hypertension in the United States
M. Ezzati (2008)
10.1161/HYPERTENSIONAHA.111.00601
Resistant hypertension.
R. Carey (2013)
10.1016/S0140-6736(00)02527-7
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
M. Brown (2000)
10.1038/jhh.2015.122
Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology
Th. Denolle (2016)
The Cochrane Database of Systematic Reviews
A. O’Connor (2004)
10.1016/j.jash.2015.07.004
Urinary sodium or potassium excretion and blood pressure in adults of Shandong province, China: preliminary results of the SMASH project.
X. Chen (2015)
10.1161/STR.0000000000000024
Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
W. Kernan (2014)
10.1016/S0140-6736(18)30951-6
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
D. Kandzari (2018)
Aggregation analysis
continents. Lancet (2016)
Efficacy and safety of compound reserpine triamterene tablets (Bump No. 0) and indapamide in the treatment of patients with essential hypertension Randomized controlled clinical study
HY Wang (2016)
Comparison of active
JG Wang (2010)
10.1097/00132578-200307000-00027
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
A. Chobanian (2003)
10.1016/S0140-6736(00)03307-9
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
B. Neal (2000)
10.1016/S0140-6736(07)61303-8
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel (2007)
10.1016/j.jacc.2011.06.008
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
J. Bisognano (2011)
10.1016/j.ejvs.2008.01.007
Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
D. Singer (2008)
10.1097/01.hjh.0000194120.42722.ac
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
L. Liu (2005)
10.1016/j.ijcard.2014.11.013
Cardiovascular remodeling relates to elevated childhood blood pressure: Beijing Blood Pressure Cohort Study.
Y. Liang (2014)
10.1001/jama.2015.2274
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
Y. Huo (2015)
jing: People's Medical Publishing House, 2006. [In Chinese
JD Douketis (2006)
Mineralocorticoid antagonists
OA Dhaybi (2009)
blocker vs diuretic
FH Leenen (2003)
Effect of long- act
J Lubsen (2010)
com; jgc@mail.sciencep.com | Journal of Geriatric Cardiology organ damage in patients with obstructive sleep apnea-related hypertension
Nan-Fang Li (2011)
10.7326/M15-2112
Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force
E. Whitlock (2016)
10.1038/ajh.2011.166
Remodeling of retinal small arteries in hypertension.
M. V. Lehmann (2011)
10.1097/01.AOG.0000437382.03963.88
Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.
James M. Roberts (2013)
10.1161/01.HYP.37.3.869
Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives: Analysis Based on National Health and Nutrition Examination Survey (NHANES) III
S. Franklin (2001)
10.1161/01.HYP.35.2.544
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.
J. He (2000)
10.1161/01.HYP.17.4.579
Metoprolol Versus Thiazide Diuretics in Hypertension Morbidity Results From the MAPHY Study
J. Wikstrand (1991)
10.1001/jama.2010.221
Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.
F. G. Fowkes (2010)
Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
A. Haenni (1999)
10.1161/HYPERTENSIONAHA.107.102145
Impacts of Measurement Protocols on Blood Pressure Tracking From Childhood Into Adulthood: A Metaregression Analysis
X. Chen (2008)
10.1016/S0140-6736(03)14286-9
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
K. Fox (2003)
10.1111/jch.13159
Failure to confirm high blood pressures in pediatric care—quantifying the risks of misclassification
C. Koebnick (2018)
10.1056/NEJMoa1001286
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
W. Cushman (2010)
10.1016/S0140-6736(16)30175-1
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
Global BMI Mortality Collaboration (2016)
10.1136/bmjopen-2013-003798
Prevalence of diabetes mellitus in outpatients with essential hypertension in China: a cross-sectional study
J. Liu (2013)
Effect of cardiovascular
HH (2011)
Guidelines for prevention and treatment of dyslipidemia in Chinese adults (revised 2016)
JR Zhu (2016)
Association of physical activity with risk of metabolic syndrome: findings from a cross-sectional study conducted in rural area
J Xiao (2016)
Primary care-based lifestyle interventions on blood pressure and lipid profiles among Chinese subjects: a meta-analysis. World Congress of Cardiology Scientific Sessions
Hhx Wang (2012)
A nationwide cross-sectional
W Shi (2006)
Cardiovascular prog
G Bobrie (2015)
China Cardiovascular Disease Report
L Z Kong (2010)
10.1056/NEJMoa1304127
Global sodium consumption and death from cardiovascular causes.
D. Mozaffarian (2014)
10.1136/bmj.f1378
Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses
N. J. Aburto (2013)
10.1161/HYPERTENSIONAHA.107.089763
Prevention of Stroke and Myocardial Infarction by Amlodipine and Angiotensin Receptor Blockers: A Quantitative Overview
J. Wang (2007)
10.1016/j.ijcard.2014.07.017
Adherence to dietary guidelines and cardiovascular disease risk in the EPIC-NL cohort.
E. Struijk (2014)
10.1056/NEJMc1503870
Less-tight versus tight control of hypertension in pregnancy.
A. Tita (2015)
10.7326/M15-2113
Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force
J. Guirguis-Blake (2016)
10.7326/0003-4819-144-7-200604040-00007
Effects of Comprehensive Lifestyle Modification on Diet, Weight, Physical Fitness, and Blood Pressure Control: 18-Month Results of a Randomized Trial
P. Elmer (2006)
10.1016/S1062-1458(02)01011-5
Exercise type and intensity in relation to coronary heart disease in men.
M. Tanasescu (2002)
10.1161/01.CIR.0000039105.49749.6F
Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
D. Lloyd-Jones (2002)
10.1097/HJH.0b013e328013e7f4
Incidence and predictors of hypertension over 8 years among Chinese men and women
Dongfeng Gu (2007)
Post-stroke antihypertensive treatment study. A preliminary result.
Pats (1995)
10.1016/j.annemergmed.2007.07.003
High-dose atorvastatin after stroke or transient ischemic attack.
J. Farmer (2007)
10.1016/S0140-6736(05)66375-1
Prevalence of the metabolic syndrome and overweight among adults in China
D. Gu (2005)
10.1111/jch.13222
Identifying elevated blood pressure and hypertension in children and adolescents
S. Li (2018)
diabetes and
(2007)
Prevalence, awareness
Y Zheng (2016)
CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS
Aniel (2000)
10.1097/00004872-200305000-00011
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
H. Lithell (2003)
10.1161/01.HYP.0000094221.86888.AE
Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
J. E. Neter (2003)
10.1097/HJH.0b013e328308da66
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring
G. Parati (2008)
10.1161/01.HYP.29.4.930
Nutrient intake and blood pressure in the Dietary Intervention Study in Children.
D. Simons-Morton (1997)
10.1111/j.1471-0528.2010.02847.x
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
R. Cantwell (2011)
10.1038/jhh.2010.19
Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION' database in patients with angina
Hl Elliott (2011)
European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents
E Lurbe (2016)
Athletic http://www.jgc301.com; jgc@mail.sciencep.com | Journal of Geriatric Cardiology participation by children and adolescents who have systemic hypertension
T M Mccambridge (2010)
rillation in women
MJ Klag (2009)
Reference standards for gender, age and height in Chinese children aged 3 to 17 years
H Fan (2017)
Chinese Medical Association Cardiovascular Branch, Editorial Board of Chinese Journal of Cardiovascular Diseases. [Guidelines for the diagnosis and treatment of heart failure in China
(2014)
Evaluation of the quality
EY
10.1016/S0140-6736(15)00340-2
Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies
Z. Chen (2015)
10.1016/S0140-6736(09)60503-1
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Antithrombotic Trialists' (ATT) Collaboration (2009)
10.1056/NEJMoa1107039
Apixaban versus warfarin in patients with atrial fibrillation.
C. Granger (2011)
10.1097/00004872-199602000-00011
Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension
B. Agrawal (1996)
10.1016/S0140-6736(15)00257-3
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
B. Williams (2015)
10.1056/NEJMoa0905561
Dabigatran versus warfarin in patients with atrial fibrillation.
S. Connolly (2009)
10.2337/dci17-0026
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
I. D. de Boer (2017)
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
J. Staessen (1997)
10.1056/NEJMc1112233
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
S. Pearson (2011)
10.1016/S0140-6736(04)16895-5
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
H. Colhoun (2004)
10.1016/S0140-6736(99)10327-1
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
L. Hansson (1999)
10.1016/j.semerg.2015.12.009
[A randomized trial of intensive versus standard blood pressure control].
J. A. Divisón Garrote (2016)
ease: a Canadian perspective
HC Park (2007)
Post-study era of SIMPLICITY HTN 3: The status and challenges of denervation for the treatment of refractory hypertension
XJ Jiang (2014)
Multi-center, prospective Chinese heart
J Zhang (2005)
Investigation and analysis of target organ damage in sleep apnea-related hypertension
Zhang Yu (2011)
Experts Association of Angiotensin-Converting Enzyme Inhibitors Correctly Applied in Kidney Diseases
Prevalence and trends of isolated systolic hypertension among Korean adults: the Korea national health and nutrition examination survey
N R Kim (1998)
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents
(2004)
10.1161/CIR.0b013e31821daaf6
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
W. Aronow (2011)
10.1161/01.HYP.0000231662.77359.de
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
F. Leenen (2006)
10.1007/s00467-013-2715-1
Screening blood pressure measurement in children: are we saving lives?
T. Brady (2013)
10.1161/CIRCULATIONAHA.117.032380
Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015
Z. Wang (2018)
10.1056/NEJMoa0801369
Treatment of hypertension in patients 80 years of age or older.
N. Beckett (2008)
10.1136/bmj.293.6555.1145
Randomised trial of treatment of hypertension in elderly patients in primary care.
J. Coope (1986)
10.1097/00004872-199816120-00016
Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
L. Liu (1998)
10.1097/00008483-200105000-00012
EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET
Rank (2000)
10.1016/S0140-6736(07)61124-6
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
S. Oparil (2007)
10.1001/jama.2014.18574
Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
C. Emdin (2015)
10.1016/j.jns.2012.02.014
Anxiety, depression and autonomic nervous system dysfunction in hypertension
Z. Bajkó (2012)
Influence of systolic
D Conen (2002)
Benefits of modest
RR Wing (2005)
dle-aged Chinese population
CS Fox (2015)
Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017,140
JT Flynn (2017)
Systematic review of Chinese
Y Shang (2013)
China's Guidelines for the Prevention and Treatment of Hypertension
(2010)
Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey
E Selvin (1999)
Study on the relationship between risk factors and risk of hypertension in community population in Shanghai
G Wang
Comparative analysis of multiple risk factors for metabolic syndrome in community population in Guiyang City
Z Y Zhou
10.1001/archinte.168.7.713
Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.
T. Fung (2008)
10.3967/0895-3988.2013.06.004
The association of overweight and obesity with blood pressure among Chinese children and adolescents.
B. Dong (2013)
10.1097/00004872-199917060-00003
Hypertensive men who exercise regularly have lower rate of cardiovascular mortality.
G. Engström (1999)
10.1097/HJH.0b013e3282b9714b
Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial
N. Li (2007)
10.1016/J.REC.2011.11.007
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases
M. Tendera (2012)
10.7326/M13-2981
Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View
J. Wright (2014)
10.1016/j.jvs.2006.12.037
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
L. Norgren (2007)
Drug treatment of hypertension in the elderly: a meta-analysis.
J. Insua (1994)
10.1016/j.ypmed.2013.09.023
Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009.
B. Xi (2013)
10.1016/S0140-6736(98)04311-6
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
L. Hansson (1998)
10.1001/JAMA.287.24.3215
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
P. Serruys (2002)
10.1097/HJH.0000000000001118
Childhood body mass index and blood pressure in prediction of subclinical vascular damage in adulthood: Beijing blood pressure cohort
Yinkun Yan (2017)
Dietary sources
CA Anderson (2015)
Relationship between MTHFR gene polymorphism and plasma homocysteine levels and stroke
X L Zhou
Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
MrcBhf (2002)
com; jgc@mail.sciencep.com | Journal of Geriatric Cardiology loss from lifestyle intervention benefits blood pressure?: a systematic review
L Aucott (2009)
National Health and Family Planning Commission Disease Prevention and Control Bureau
(2015)
Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S
JM Guirguis-Blake (2016)
Chinese expert guidance on the management of salt intake to control hypertension
(2015)
10.1517/14656566.2013.798646
Improved perioperative blood pressure control leads to reduced hospital costs
Denis Getsios (2013)
10.3760/CMA.J.ISSN.1000-6699.2011.09.005
Prevalence of metabolic syndrome in patients with primary aldosteronism
Xuan Ma (2011)
10.1016/j.jada.2010.02.007
Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study.
C. Anderson (2010)
10.1001/ARCHINTE.166.7.787
Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
N. Danchin (2006)
10.1093/oxfordjournals.aje.a008798
Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial.
S. Mark (1996)
10.1080/03007995.2016.1218833
The efficacy of renal artery stent combined with optimal medical therapy in patients with severe atherosclerotic renal artery stenosis
Xiongjing Jiang (2016)
10.1161/01.HYP.0000170138.56903.7a
Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study
E. Dolan (2005)
10.1016/s0095-5108(18)30498-6
Chronic hypertension in pregnancy.
J. Livingston (2001)
10.1016/S0140-6736(10)62003-X
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
M. Brown (2011)
10.1056/NEJMoa1600175
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
E. Lonn (2016)
10.1111/jch.13501
An expert recommendation on salt intake and blood pressure management in Chinese patients with hypertension: A statement of the Chinese Medical Association Hypertension Professional Committee
Ningling Sun (2019)
10.1097/01.hjh.0000431740.32696.cc
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
G. Mancia (2013)
10.1016/0140-6736(90)90944-Z
Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context
R. Collins (1990)
The combination of amlodi
L Ma (2007)
rate: the Finn-Home Study
WW (2012)
Chinese Guidelines for Prevention and Treatment of Hypertension
LS LIU (2018)
Prevalence of the metabolic
Group. Lancet (1998)
Effects of a fixed
A Patel (2008)
Telmisartan, ramipril
S Yusuf (2006)
Efficacy and safety of irbesartan in the treatment of type 2 diabetes with albuminuria: a multicenter randomized double-blind controlled study
W Z Zong
The relationship between different components and combinations of metabolic syndrome and cardiovascular disease in 11 provinces of China
J Liu
Intersalt revisited: further
P Elliott (2007)
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials
SP Whelton (2002)
10.1016/j.jvs.2005.04.037
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
J. Larosa (2005)
Blood pressure in obese adolescents: effect of weight loss.
A. Rocchini (1988)
10.1016/j.jacc.2009.10.061
Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.
C. Vlachopoulos (2010)
10.1016/j.accreview.2005.02.063
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
S. Nissen (2004)
10.1016/0895-7061(96)82140-6
Shanghai trial of nifedipine in the elderly (STONE).
L. Gong (1996)
10.1161/HYPERTENSIONAHA.107.092197
Left Ventricular Hypertrophy in Hypertensive Adolescents: Analysis of Risk by 2004 National High Blood Pressure Education Program Working Group Staging Criteria
K. McNiece (2007)
10.1038/jhh.2010.45
The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics
W. Wang (2011)
10.1016/j.jelectrocard.2012.08.051
A review of the role of electrocardiography in the diagnosis of left ventricular hypertrophy in hypertension.
G. Schillaci (2012)
Ministry of Health of the People's Republic of China. [Guidelines for Prevention and Control of Overweight and Obesity in Adults in China
(2006)
The efficacy of renal artery
X Jiang (2017)
10.1097/MD.0000000000001551
Relationship of Blood Pressure With Mortality and Cardiovascular Events Among Hypertensive Patients aged ≥60 years in Rural Areas of China
Liqiang Zheng (2015)
Moxonidine improves insulin sensitivity
A Haenni (1991)
10.1161/01.STR.27.8.1274
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.
W. Longstreth (1996)
10.1001/jamainternmed.2016.0190
The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China.
S. Lewington (2016)
10.1136/bmj.g4164
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
M. Holmes (2014)
10.1161/HY1101.093424
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
X. Xin (2001)
10.1093/EJCTS/EZW313
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
P. Kirchhof (2016)
10.1056/NEJMOA011303
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
Edmund J. Lewis (2001)
10.1111/jch.12237
Clinical Practice Guidelines for the Management of Hypertension in the Community
M. Weber (2014)
10.1097/HJH.0b013e3283653999
Long-term alcohol consumption is an independent risk factor of hypertension development in northern China: evidence from Kailuan study
M. Peng (2013)
10.1097/MNH.0000000000000290
Mineralocorticoid antagonists in chronic kidney disease
O. Dhaybi (2017)
10.1056/NEJM199901073400103
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.
D. O'leary (1999)
10.1016/j.numecd.2014.06.008
Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials.
P. Saneei (2014)
10.1161/CIRCULATIONAHA.108.797936
Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease: The Framingham Heart Study
S. Franklin (2009)
10.1016/j.ejheart.2005.09.006
Clinical trials update from the European Society of Cardiology meeting 2005: CARE‐HF extension study, ESSENTIAL, CIBIS‐III, S‐ICD, ISSUE‐2, STRIDE‐2, SOFA, IMAGINE, PREAMI, SIRIUS‐II and ACTIVE
J. Cleland (2005)
10.1161/HYPERTENSIONAHA.111.182956
Unusual hypertensive phenotypes: what is their significance?
S. Franklin (2012)
10.1038/ajh.2009.134
Dietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveys.
Zhiquan Liu (2009)
[The prevalence of metabolic syndrome].
S. Bryssine (2010)
People's Medical Publishing House 2015; 33–50. [In Chinese
Z. Liu (2015)
Prevalence of hypertension in some ethnic groups in China
Y S Hu (2002)
Effects of alcohol reduction
X Xin (2007)
Effectiveness of lifestyle interventions in reducing cardiovascular risk factors among Chinese subjects in primary care setting: a systematic review
Hhx Wang (2011)
Carotid-wall in-Journal of Geriatric Cardiology | jgc@jgc301
J F Polak (2011)
10.1097/01.hjh.0000419838.43636.bb
12 EFFECT OF CARDIOVASCULAR RISK-BASED APPROACH IN PRIMARY CARE PHYSICIAN-LED MANAGEMENT FOR 19,400 HYPERTENSIVE PATIENTS IN SOUTHERN CHINA
Harry H X Wang (2012)
10.1001/jama.2013.1644
Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.
C. Clair (2013)
10.1007/s11906-014-0448-6
Perioperative Hypertensive Emergencies
Solomon Aronson (2014)
10.1016/S0140-6736(02)08090-X
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
L. Lindholm (2002)
10.1007/978-0-387-39940-9_2232
Comparative Analysis
A. Conversi (2009)
10.1016/0140-6736(91)92589-T
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
B. Dahlöf (1991)
Multiple risk factor clustering and risk of hypertension in the Mongolian ethnic population of China.
Chang-Qing Ying (2007)
10.1136/bmj.d643
Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts
J. Sundström (2011)
10.1161/HYPERTENSIONAHA.111.178657
Prognostic Value of the Variability in Home-Measured Blood Pressure and Heart Rate: The Finn-Home Study
J. Johansson (2012)
10.1097/HJH.0b013e3283350ea4
Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure
E. Lambert (2010)
10.1161/01.HYP.37.2.187
Association Between Smoking and Blood Pressure: Evidence From the Health Survey for England
P. Primatesta (2001)
Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
S. MacMahon (2001)
10.1161/01.HYP.29.4.913
Long-term effects of neonatal sodium restriction on blood pressure.
J. M. Geleijnse (1997)
10.1016/j.cjca.2011.09.004
Automated office blood pressure.
M. Myers (2012)
10.1038/jhh.2015.40
Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China
M. Peng (2016)



This paper is referenced by
10.1038/s41371-019-0277-9
Changes in blood pressure during the transition of retirement: the role of physical activity in China
Qingyuan Wang (2019)
10.1080/00325481.2020.1743114
Association between regular aerobic exercise and hyperhomocysteine in hypertensive patients
W. Wang (2020)
10.1016/j.cjca.2019.08.039
Takayasu Arteritis With Coronary Artery Involvement: Differences Between Pediatric and Adult Patients.
Chuxiang Lei (2019)
10.1016/j.jstrokecerebrovasdis.2019.104581
Comparison of Prediction Models based on Risk Factors and Retinal Characteristics Associated with Recurrence One Year after Ischemic Stroke.
Zhuo Yuanyuan (2020)
10.1038/s41440-020-0429-x
Home-measured orthostatic hypotension associated with cerebral small vessel disease in a community-based older population
Yi Fang Cui (2020)
Gender-specifi c associations of anthropometric measures of adiposity with blood pressure and hypertension in young Chinese Medical College Students
Navin Kumar Sah (2020)
10.1007/978-981-15-0591-1_17
Hypertensive Diseases in Female and Pregnancy
Delian Zhang (2020)
10.1038/s41598-020-60153-9
Association between Dietary Quality and Prediabetes based on the Diet Balance Index
Dingliu He (2020)
10.1007/978-981-15-0591-1_5
Renal Parenchymal Hypertension
Nuerguli Maimaiti (2020)
10.1016/j.amjcard.2020.05.035
Baseline CHADS2 Score and Risk of Cardiovascular Events in the Population Without Atrial Fibrillation.
Chun-peng Ji (2020)
10.1111/jch.13793
Blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy in patients with hypertension and diabetes
W. Zhang (2020)
10.1111/jch.13803
What is new in the 2018 Chinese hypertension guideline and the implication for the management of hypertension in Asia?
J. Wang (2020)
10.1186/s40885-020-00141-3
Highlights of the 2018 Chinese hypertension guidelines
J. Liu (2020)
10.3892/etm.2019.7618
Clinical characteristics of patients with premature acute coronary syndrome and adverse cardiovascular events after PCI
Xiao-jun Shi (2019)
10.1093/ajh/hpaa083
Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients
Dongqing Wang (2020)
10.1186/s13098-020-0517-8
Analysis of risk factors for carotid intima-media thickness in patients with type 2 diabetes mellitus in Western China assessed by logistic regression combined with a decision tree model
Yuanyuan Zhou (2020)
10.1155/2020/2563508
Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure
S. Yang (2020)
10.1111/jch.13850
Barriers to blood pressure control in China in a large opportunistic screening
Xinjie Chen (2020)
10.1111/jch.13680
Cardiovascular risk stratification in Chinese patients with hypertension
Weizhong Zhang (2019)
10.1007/s11136-019-02336-0
Evaluation of health-related quality of life in adults with and without dyslipidaemia in rural areas of central China
H. Wu (2019)
10.1007/s11096-020-00986-6
Trends of antihypertensive agents in patients with hypertension and coronary artery disease in a tertiary hospital of China
Yingming Zheng (2020)
10.1111/jch.13714
Target blood pressure and control status in Asia
Y. Chia (2019)
10.1111/jch.13750
The HOPE Asia Network activity for “zero” cardiovascular events in Asia: Overview 2020
K. Kario (2020)
10.1177/2040622320901660
Clinical applications for out-of-office blood pressure monitoring
H. Zhu (2020)
10.1111/ijcp.13426
Expert consensus on the management of hypertension in the young and middle‐aged Chinese population
J. Liu (2019)
10.1111/jch.13875
The cumulative blood pressure load and target organ damage in patients with essential hypertension
Bingqing Zhou (2020)
Semantic Scholar Logo Some data provided by SemanticScholar